The latest intel suggests the spine market is rebounding more quickly than expected, but certain new market dynamics will persist.
SmartTRAK is now modeling a ~45% impact to US spine procedures in Q2 versus previous expectations of 73% of Q2 cases being impacted.
Of deferred spinal fusion procedures, surgeons surveyed by WFS expect 74% of cases to be performed at a later date with 26% cancelling. Reasons for cancellation include patient seeking treatment with a different surgeon (26%) and underlying condition improving (23%). One survey of AAOS surgeons suggests that 70% believe it will take five months to regain 90% of pre-COVID orthopedic surgical volumes once cases resume, while surgeons queried by WFS analysts estimate it will be ...
To continue reading the Spine Market COVID-19 Update article, just click the button below to download the complete analysis.
SmartTRAK is a comprehensive, easy-to-use, business intelligence solution that networks an entire organization with real-time market data and analysis. Used by the 8 of the top 10 orthopedic companies and by 15 of the top 15 advanced wound care companies, SmartTRAK transforms the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity and reduce cost.
